VYVGART HYTRULO faces a new FDA safety signal related to CIDP, but I believe this is not a major concern for the franchise. The main issue is the transition from IVIg to VYVGART HYTRULO in real-world ...

Argenx SE (NASDAQ:ARGX) stock is trading lower on Monday after the U.S. Food and Drug Administration (FDA) signaled serious risks/safety identified by the reporting system for Vyvgart Hytrulo ...

WAYNE, Pennsylvania (WPVI) -- One step at a time, those who are diagnosed with rare neuropathic conditions such as GBS or CIDP prove it's possible to get back on their feet. A great place to see their ...

A new COVID-19 strain, referred to as NB.1.8.1 or "Nimbus," first appeared in the U.S. sometime near the end of April and is currently the dominant variant in the U.S. The new variant is said to be ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

Like it or not, COVID-19 is still a public health issue five years after the start of the pandemic flipped the nation, and the world, on its head. Here is a brief recap of the status of COVID cases, ...

The new Covid variant is continuing to proliferate around the U.S. — although you might not know it by just checking federal variant-tracking dashboards. Known as NB.1.8.1, the omicron variant has ...

Immunovant IMVT announced top-line data from a late-stage study of its investigational candidate, batoclimab, for myasthenia gravis (MG) and initial results from Period 1 of a mid-stage study of the ...

Having played games for most of her life, Madie Bostwick has evolved from a fan to an expert on all her favorites. When it comes to the Pokémon franchise specifically, she's caught them all, and then ...

Argenx is urging patients to “Live Vyvidly.” The biotech put the message out in a direct-to-consumer TV ad that paints Vyvgart Hytrulo as a drug that can help people with chronic inflammatory ...

Vyvgart Hytrulo (efgartigimod alfa/hyaluronidase-qvfc) is a prescription medicine that is used to treat certain muscle and nerve conditions. It is a combination of two medicines, efgartigimod alfa and ...